Welcome to our dedicated page for Careview Comm SEC filings (Ticker: CRVW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CareView Communications, Inc. SEC filings document material financing events and public-company disclosures for its virtual care and patient safety business. Recent 8-K reports focus on amendments to a credit agreement involving the company, its wholly owned Texas subsidiary as borrower, and PDL Investment Holdings, LLC as lender.
The filings describe maturity-date extensions, direct financial obligations, exhibits to credit-agreement amendments, registrant information for the Nevada corporation, and related material definitive agreement disclosures. The record emphasizes capital-structure and debt-arrangement updates rather than operating contract announcements.
CareView Communications, Inc. reported a first-quarter 2026 net loss of $756,200 on revenue of $2,191,342, with revenue slightly below the prior year as lower first-year software bundle revenue offset modest subscription growth. Operating income turned positive at $30,843, but heavy interest expense kept overall results in a loss.
The balance sheet remains highly leveraged: total assets were $4.8M against total liabilities of $48.4M, including $20.7M of notes payable and $23.7M of accrued interest. Stockholders’ deficit was $43.6M and the working capital deficit was $44.0M as of March 31, 2026.
Cash was $1.4M with operating cash outflows of $126,166 in the quarter. Management concluded that recurring net losses and the sizable working capital deficit raise substantial doubt about the company’s ability to continue as a going concern without additional funding.
The company extended its long‑standing credit agreement with PDL BioPharma via a Fourteenth Amendment, pushing the maturity date to June 30, 2026 while the $20.7M note balance remained unchanged. Management accounted for this as a troubled debt restructuring under ASC 470‑60. CareView also disclosed a material weakness in internal control over financial reporting related to technical accounting, though it believes the financial statements are fairly presented.
CareView Communications, Inc. entered into a Fourteenth Amendment to its long-standing Credit Agreement with PDL Investment Holdings, LLC and related parties. The amendment, signed with the company’s CEO Steven G. Johnson and director Dr. James R. Higgins, extends the loan’s Maturity Date to June 30, 2026.
This change is reported as both the entry into a material definitive agreement and the creation of a direct financial obligation, continuing a series of credit agreement and modification amendments that date back to 2015.
CareView Communications, Inc. reports 2025 revenue of $9.0 million, up from $8.3 million in 2024, driven mainly by higher recurring software revenue. Operating loss narrowed sharply to about $55,000, compared with $1.6 million the prior year, and net loss improved to roughly $3.2 million.
Cash from operating activities turned positive at about $0.8 million, lifting year-end cash to $1.55 million. However, the company discloses a substantial accumulated deficit of about $215.8 million and a working capital deficit of roughly $43.5 million, and management concludes there is substantial doubt about its ability to continue as a going concern without additional funding.
CareView highlights growth in its sales-based contract model, with approximately $2.53 million of aggregated contract sales price signed in 2025 and sales-based contract backlog of about $5.07 million. Subscription contracts add an expected 2025 annual subscription billable of around $4.07 million. The company continues to expand distribution through group purchasing and government-related agreements, and reports a material weakness in internal control over financial reporting related to technical accounting matters.
CareView Communications, Inc. reported that it entered into a Thirteenth Amendment to its existing Credit Agreement with PDL Investment Holdings, LLC as of December 31, 2025. This new amendment extends the loan’s maturity date to March 31, 2026, giving the company more time before the outstanding debt under this facility comes due.
The amendment involves the company, its Texas subsidiary as borrower, and its long‑time lender, and also lists President and Chief Executive Officer Steven G. Johnson and director Dr. James R. Higgins as parties. The filing cross‑references this amendment as a direct financial obligation of the company and includes the full agreement as Exhibit 10.45.
CareView Communications (CRVW) filed its Q3 2025 10‑Q, showing modest top‑line growth and narrower losses alongside ongoing balance sheet pressure. Revenue for the quarter was $2,064,535 versus $1,932,382 a year ago, driven primarily by software recognized over time. Operating loss improved to $132,467 from $684,476, and net loss narrowed to $914,214 from $1,470,655. For the nine months, revenue reached $6,682,928 (vs. $6,109,259) with an operating loss of $68,406.
Liquidity remains tight. Cash was $1,731,276 as of September 30, 2025. The company reported a working capital deficit of $42,789,653 and a stockholders’ deficit of $42,391,690, and disclosed substantial doubt about continuing as a going concern. Notes payable totaled $20,700,000 with maturity extended to December 31, 2025; accrued interest payable was $22,094,014. Deferred revenue stood at $3,082,405, scheduled to be recognized over the next periods.
Cash provided by operating activities was $1,033,269 for the nine months, reflecting improved collections and deferred revenue activity while interest expense continued to weigh on results.
CareView Communications, Inc. filed a Form 8-K reporting the Twelfth Amendment to its credit agreement dated in the report as of September 30, 2025. The amendment lists the parties as the company (including a Texas corporate designation), PDL Investment Holdings, LLC, Steven G. Johnson, and Dr. James R. Higgins. The filing is signed by Steven G. Johnson, Chief Executive Officer, on October 2, 2025. The 8-K notice identifies the existence of the amendment but does not include the amendment's terms, financial amounts, or any changes to covenants or maturity dates within the disclosed text. Because the document provides only the amendment notice and parties, no additional financial or contractual details are available from this filing.